DANIELLE FRYE: Open Payments
NPI 1912777566 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 10 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,295 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $128 |
| ABBVIE INC. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $124 |
| Genmab U.S., Inc. | 1 | $123 |
| SERVIER PHARMACEUTICALS LLC | 1 | $122 |
| PFIZER INC. | 1 | $117 |
| PharmaEssentia USA Corporation | 1 | $102 |
| Azurity Pharmaceuticals, Inc. | 1 | $29 |
| Incyte Corporation | 1 | $27 |
| Tempus AI, Inc | 1 | $25 |
Products named: LIBTAYO, ICLUSIG, Epkinly, ADCETRIS, BESREMI, DANZITEN, MONJUVI, XT CDX.
Industry payments across FL — which companies pay providers there.
